[Federal Register Volume 67, Number 33 (Tuesday, February 19, 2002)]
[Notices]
[Page 7383]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-3952]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Cooperative Family Registry for Colorectal Cancer Studies.
    Date: March 1, 2002.
    Time: 8:30 a.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Double Tree Hotel, 1750 Rockville Pike, Rockville, MD 
20852.
    Contact Person: Gerald G. Lovinger, PhD, Scientific Review 
Administrator, Special Review and Resources Branch, Division of 
Extramural Activities, National Cancer Institute, National 
Institutes of Health, 6116 Executive Boulevard, Room 8101, 
Rockville, MD 20892-7405, 301/496-7987.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Enhancing T Cell Therapy of Cancer.
    Date: March 13, 2002.
    Time: 1 p.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: 6116 Executive Blvd., Rockville, MD 20892 (Telephone 
Conference Call).
    Contact Person: William D. Merritt, PhD, Scientific Review 
Administrator, Grants Review Branch, National Cancer Institute, 
National Institutes of Health, 6116 Executive Boulevard, Room 8034, 
MSC 8328 Bethesda, MD 20892-8328, 301-496-9767.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Letter RFA Advanced Technology Radiation Therapy.
    Date: March 14, 2002.
    Time: 1:30 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: 6116 Executive Boulevard, 8th Floor, Room 8023, 
Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Gerald G. Lovinger, PhD, Scientific Review 
Administrator, Special Review and Resources Branch, Division of 
Extramural Activities, National Cancer Institute, National 
Institutes of Health, 6116 Executive Boulevard, Room 8101, 
Rockville, MD 20892-7405, 301/496-7987.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS.)

    Dated: February 12, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-3952 Filed 2-15-02; 8:45 am]
BILLING CODE 4140-01-M